Experimental data and PBPK modeling quantify antibody interference in PEGylated drug carrier delivery (Q2051453): Difference between revisions
From MaRDI portal
Changed an Item |
Created claim: Wikidata QID (P12): Q113900118, #quickstatements; #temporary_batch_1714639695901 |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Property / MaRDI profile type | |||
| Property / MaRDI profile type: MaRDI publication profile / rank | |||
Normal rank | |||
| Property / full work available at URL | |||
| Property / full work available at URL: https://doi.org/10.1007/s11538-021-00950-z / rank | |||
Normal rank | |||
| Property / OpenAlex ID | |||
| Property / OpenAlex ID: W3212245988 / rank | |||
Normal rank | |||
| Property / Wikidata QID | |||
| Property / Wikidata QID: Q113900118 / rank | |||
Normal rank | |||
Latest revision as of 10:49, 2 May 2024
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Experimental data and PBPK modeling quantify antibody interference in PEGylated drug carrier delivery |
scientific article |
Statements
Experimental data and PBPK modeling quantify antibody interference in PEGylated drug carrier delivery (English)
0 references
24 November 2021
0 references
PBPK model
0 references
Latin hypercube sampling
0 references
parameter optimization
0 references
anti-PEG antibodies
0 references
pegylated liposomes
0 references
